Fenwick Represents DaVita Venture Group in Heartbeat Health’s $20 Million Series B Financing

Fenwick represented Davita Venture Group, the corporate venture arm of healthcare provider DaVita Inc., in its investment in Heartbeat Health, a healthcare company working to deliver effective, efficient and engaging heart care, as part of a $20 million Series B financing. The round was led by Echo Health Ventures with participation from DaVita Venture Group and existing investors .406 Ventures, Optum Ventures, Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures.

The funds will allow Heartbeat Health to accelerate product research and development, as well as expand clinical services offered to at-risk organizations. More information can be obtained from Heartbeat Health’s announcement.

The Fenwick transaction team was led by corporate partner Ian Goldstein and included associates Ryan M. McRobert and Gabriel Malone-O’Meally.